A detailed history of Voya Investment Management LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Voya Investment Management LLC holds 13,957 shares of PRTA stock, worth $212,425. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,957
Previous 30,872 54.79%
Holding current value
$212,425
Previous $637,000 63.42%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$16.73 - $24.79 $282,987 - $419,322
-16,915 Reduced 54.79%
13,957 $233,000
Q2 2024

Dec 03, 2024

BUY
$19.54 - $26.15 $330,519 - $442,327
16,915 Added 121.19%
30,872 $637,000
Q2 2024

Aug 14, 2024

SELL
$19.54 - $26.15 $250,151 - $334,772
-12,802 Reduced 29.31%
30,872 $637,000
Q1 2024

Dec 06, 2024

BUY
$24.75 - $40.66 $735,495 - $1.21 Million
29,717 Added 212.92%
43,674 $1.08 Million
Q1 2024

May 15, 2024

SELL
$24.75 - $40.66 $64,053 - $105,228
-2,588 Reduced 5.59%
43,674 $1.08 Million
Q4 2023

Feb 14, 2024

SELL
$32.31 - $52.32 $1.44 Million - $2.33 Million
-44,449 Reduced 49.0%
46,262 $1.68 Million
Q3 2023

Nov 14, 2023

SELL
$47.3 - $70.6 $2.41 Million - $3.6 Million
-50,923 Reduced 35.95%
90,711 $4.38 Million
Q2 2023

Aug 14, 2023

BUY
$48.26 - $78.59 $4.97 Million - $8.1 Million
103,087 Added 267.43%
141,634 $9.67 Million
Q1 2023

May 15, 2023

BUY
$46.97 - $58.27 $25,692 - $31,873
547 Added 1.44%
38,547 $1.87 Million
Q4 2022

Feb 14, 2023

BUY
$52.05 - $65.0 $552,250 - $689,650
10,610 Added 38.74%
38,000 $2.29 Million
Q3 2022

Mar 03, 2023

SELL
$25.16 - $60.63 $266,947 - $643,284
-10,610 Reduced 27.92%
27,390 $1.66 Million
Q3 2022

Nov 14, 2022

BUY
$25.16 - $60.63 $342,050 - $824,264
13,595 Added 98.55%
27,390 $1.66 Million
Q2 2022

Aug 15, 2022

SELL
$22.73 - $39.98 $11,365 - $19,990
-500 Reduced 3.5%
13,795 $375,000
Q1 2022

May 16, 2022

BUY
$30.27 - $49.22 $20,159 - $32,780
666 Added 4.89%
14,295 $523,000
Q4 2021

Feb 14, 2022

SELL
$42.11 - $73.26 $5,811 - $10,109
-138 Reduced 1.0%
13,629 $673,000
Q3 2021

Nov 15, 2021

BUY
$48.2 - $78.89 $13,592 - $22,246
282 Added 2.09%
13,767 $980,000
Q2 2021

Aug 16, 2021

SELL
$21.63 - $57.65 $7,613 - $20,292
-352 Reduced 2.54%
13,485 $693,000
Q4 2020

Feb 16, 2021

BUY
$10.12 - $13.94 $9,300 - $12,810
919 Added 7.11%
13,837 $166,000
Q3 2020

Nov 16, 2020

SELL
$9.93 - $13.47 $12,084 - $16,392
-1,217 Reduced 8.61%
12,918 $129,000
Q2 2020

Aug 14, 2020

SELL
$9.56 - $12.51 $55,992 - $73,271
-5,857 Reduced 29.3%
14,135 $148,000
Q4 2019

Feb 14, 2020

BUY
$7.48 - $17.01 $11,369 - $25,855
1,520 Added 8.23%
19,992 $316,000
Q2 2019

Aug 14, 2019

BUY
$8.85 - $12.49 $13,133 - $18,535
1,484 Added 8.74%
18,472 $195,000
Q2 2018

Aug 14, 2018

SELL
$10.99 - $44.21 $3.36 Million - $13.5 Million
-305,482 Reduced 94.73%
16,988 $248,000
Q1 2018

May 15, 2018

BUY
$27.95 - $45.04 $719,349 - $1.16 Million
25,737 Added 8.67%
322,470 $11.8 Million
Q4 2017

Feb 14, 2018

BUY
$35.44 - $63.76 $1.37 Million - $2.46 Million
38,627 Added 14.97%
296,733 $11.1 Million
Q3 2017

Nov 14, 2017

BUY
$53.83 - $67.75 $13.9 Million - $17.5 Million
258,106
258,106 $16.7 Million

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $714M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.